Recent And Upcoming FDA Advisory Committee Meetings
Executive Summary
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
Topic |
Advisory Committee |
Date |
Details |
Clarus Therapeutics' oral testosterone undecanoate capsules for testosterone replacement in males for conditions associated with a deficiency or absence of endogenous testosterone: primary hypogonadism (congenital or acquired) and hypogonadotropic hypogonadism (congenital or acquired) |
Bone, Reproductive and Urologic Drugs |
Jan. 9 |
|
Lipocine's oral testosterone undecanoate capsules for testosterone replacement in males for conditions associated with a deficiency or absence of endogenous testosterone: primary hypogonadism (congenital or acquired) and hypogonadotropic hypogonadism (congenital or acquired) |
Bone, Reproductive and Urologic Drugs |
Jan. 10 |
|
Aradigm Corp.'s ciprofloxacin dispersion for inhalation for treatment of non-cystic fibrosis bronchiectasis patients with chronic lung infections with Pseudomonas aeruginosa |
Antimicrobial Drugs |
Jan. 11 |